The Patent Finder

Terms ending in 2038

Unity Biotechnology, Inc.

Every in-force patent on Unity Biotechnology, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,111,259Acylsulfonamide Derivatives for Treating Senescence-Associated Diseases and Disorders
In force
 · High confidence
Unity Biotechnology, Inc.In forceHigh confidence
US 10,519,197Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
In force
 · High confidence
Unity Biotechnology, Inc.In forceHigh confidence
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited